Abstract
Much new information about processes of extra- and intraceIlular signaling, interactions between neuronal and glial cells, and mechanisms of ischemic damage to brain tissue on the genetic, molecular, biochemical, immune, and cellular levels, as well as about processes of brain cell survival and post-ischemic regeneration and reparation has become available in recent years. This information provides the basis for further development of neuroprotective strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Azzimondi, G., Bassein, L., Nonino, F., et al., 1995, Stroke. 26: 2040–2043.
Bctz, A. L., Yang, G. Y., Davidson, B. L., 1995, J Cerebr Blood Flow Metab. 15: 547–551.
Castillo, J., Martinez, F., Liera, R., et al., 1994, Cerebrovase Dis. 4: 56–71.
Chen, J., Li, Y., Wang, L., et al., 2002, J Neurol Sci. 199 (1–2): 17–24.
Chen, J., Nagayama, T., Jin, K., et al., 1998, J Neurosci. 18 (13): 4914–4928.
De Bilbao, F., Guarin, E., Nef, P., et al., 2000, Ellr J Neurosci. 12 (3): 921–934.
Efremova, N. M., Skvortsova, V. I., Gruden, M. A., et al., 2000, The study o1’Sl00ß protein content and of primary and secondary antibodies to S100ß in patients with acute focal cerebral ischemi a in relation to pathogenetic variants of stroke. In Modern Approaches to Diagnosis of Nervous and Psychiatric Disorders, St. Petersburg, 294 (in Russian).
Fisher, M., Bogousslavsky, J., 1998, JAMA. 279: 1298–1303.
Ginsberg, M. D., 1990, Revieves. 2: 68–93.
Ginsberg, M. D., Busto, R., 1998, Stroke. 29: 529–534.
Ginsberg. M. D., Globus, M. V. T., Busto, R., et al., 1990, The potential of combination pharmacotherapy in cerebral ischcmia. In Pharmacology of Cerebral Ischemia, pp. 499–510.
Gu, Z., Jiang, Q., Zhang, G., 2001, Neuroreporl. 12 (16): 3487–3491.
Gusev, E. I., Skvortsova, V. I., Dambinova, S. A., et al., 2000, Cerebrovasc Dis. 10: 49–60.
Hara, H., Fink, K., Endres, M., et al., 1997, J Cerebr Blood Flow Metab. 17: 370–375.
Hindfelt, B., 1976, Acta Neurol Scand. 53: 72–79.
Irving, E. A., Barone, F. C., Reith, A. D., el al, 2000, Brain Res Mol Brain Res. 77 (1): 65–75.
Khadzhiyeva, M. Kh., Skvortsova, V. I., Sherstnyov, V. V., et al., 2000, The study of neurotrophic factors and their auto-antibodies in patients with chronic ischemic brain disease. In Modern Approaches to Diagnosis of Nervous and Psychiatric Disorders, St. Petersburg, 341 (in Russian).
Lawrence, M. S., Sun, G. H., Kunis, D. M., el al., 1996, J Cerebr Blood Flow Melab. 16: 181–185.
Lekieffre, D., Benavides, J., Scatton, B., Nowicki, J. P., 1997, Brain Res. 776 (1–2): 88–95.
Lipton, P., 1999, Physiol Rev. 79 (4): 1431–1568.
Lu, A., Ran, A., Parmentier-Batteur, S., el al., 2002, J Neurochem. 81 (2): 355–364.
Mandir. A. S., Poitras, M. F., Berliner, A. R., et al., 2000, J Neurosci. 20 (21): 80058011.
Mattson, M. P., Culmsee, C., Yu, Z. F., 2000, Cell Tissue Res. 301 (1): 173–187.
Meden, P., Overgaard, K., Pedersen, H., Boysen, G., 1996, Cerebrovasc Dis. 6: 141–148.
Meden, P., Overgaard, K., Sereghy, T., Boysen, G., 1993, J Neurol Sci. 119: 209–216.
Nozaki, K., Nishimura, M., Hashimoto, N., 2001, Mol Neurobiol. 23 (1): 1–19.
Okamoto, S., Li, Z., Ju, C., et al., 2002, Proc Natl Acad Sci USA. 99 (6): 3974–3979.
Oktem, I. S., Menku, A., Akdemir, H., et al., 2000, Res Exp Med. 199 (4): 231–242.
Onal, M. Z., Li, F., Tatlisumak, T., et al., 1997, Stroke. 28: 1060–1065.
Rajdev, S., Hara, K., Kokubo, Y., et al., 2000, Ann Neurol. 47 (6): 782–791.
Schabitz, W. R., Li, F., Irie, K., et al., 1999, Stroke. 30: 427–432.
Schmid-E1saesser, R., Zausinger, S., Hungcrhuber, E., et al., 1999, Neurosurgery. 44 (1): 163–171.
Schwab, S., Schwarz, S., Spranger, M., et al., 1998, Stroke. 29: 2461–2466.
Sharp, F. R., Massa, S. M., Swanson, R. A., 1999, Trends Neurosci. 22 (3): 97–99.
Skvortsova, V.I., Gruden, M. A., Stakhovskaya, L. V., et al., 1999, Structura1 neurospecific proteins (S100 and basic myelin protein) and auto-antibodies to them as markers of neuroimmunopathological reactions in chronic ischemic brain disease. In New Technologies in Neurology and Neurosurgery at the Turn of Millennium, Stupino, pp. 180–181 (in Russian).
Skvortsova, V.I., Klushnik, T. P., Stakhovskaya, L. V., et al., 1999, The study of autoantibodies to NGF in patients with acute and chronic brain ischemia. In New Technologies in Neurology and Neurosurgery at the Turn of Millennium, Stupino, pp. 181–182 (in Russian).
Skvortsova, V. I., Myasoyedov, N. F., Klushnik, T. P., et al., 2000, Study of NGF and its auto-antibodics content in patients with acute cerebral ischemia. In Modern Approaches to Diagnosis of Nervous and Psychiatric Disorders, St. Petersburg, pp. 332–333 (in Russian).
Song, B. W., Vinters, H. V., Wu, O., Pardridg, W. M., 2002, J Pharmacol Exp Ther. 301 (2): 605–610.
Uematsu, D., Araki, N., Grecnberg, J. H., et al., 1991, Neurology. 41 (1): 88–94.
Yu, S.W., Wang, H., Poitras, M. F., et al., 2002, Science. 297 (5579): 259–263.
Zhang, Y., Pardridge, W. M., 2001, Brain Res. 889: 49–56.
Zhu, Y., Yang, G. Y., Ahlemeyer, B., et al., 2002, J Neurosci. 22 (10): 3898–3909.
Zivin, J. A., Mazzarella, V., 1991, Arch Neurol. 48: 1235–1240.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gusev, E., Skvortsova, V.I. (2003). Strategies and Prospects for Development of Neuroprotective Therapy for Brain Ischemia. In: Brain Ischemia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9248-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9248-2_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4857-3
Online ISBN: 978-1-4419-9248-2
eBook Packages: Springer Book Archive